Good News | Xie Jianzhong, Chairman of Newland Pharmaceutical, Honored as Outstanding Builder of the Cause of Socialism with Chinese Characteristics among Non-Public Economic Personages in Henan Province

Newland Pharmaceutical and Nanjing Sinuo Drug exchanged views on innovative drug development and explored opportunities for deeper collaboration.

Pursuant to the latest announcement issued by the Hong Kong Exchanges and Clearing Limited (HKEX) on 15 December 2025, the Company’s shares (Stock Code: 301277) were officially included as China Connect Securities under the Shenzhen-Hong Kong Stock Connect with effect from 22 December 2025.

Good News | The Company’s Ferrous Fumarate API Has Been Approved for Marketing

From November 28 to 30, the 16th China (Taizhou) International Pharmaceutical Expo was grandly held in Taizhou. As a high-tech enterprise integrating pharmaceutical intermediates, active pharmaceutical ingredients (API) and pharmaceutical preparations, Newland Pharmaceutical Co., Ltd. (Stock Code: 301277) attended the expo with its competitive full-industry-chain products and innovative developmen